OpenAI and moderna The companies announced that they are expanding their partnership to provide the pharmaceutical giant's employees with access to ChatGPT Enterprise, a platform that allows them to develop customizable GPTs for specific purposes.
Through ChatGPT Enterprise, users can start conversations with ChatGPTs and create GPTs by providing additional knowledge on the subject or giving instructions. Users can also choose what they can do with GPT, such as analyzing data, searching the web, and creating images.
Moderna, which first partnered with OpenAI in early 2023, tested the deployment of ChatGPT Enterprise within its workforce, allowing individual teams to create new use cases and GPTS to suit their team's needs.
Within two months of deploying ChatGPT Enterprise, Moderna says 750 GPTs were created companywide, each user had an average of 120 conversations per week through the platform, and 40% of users created a GPT. Masu.
The pharmaceutical company plans to deploy ChatGPT Enterprise to thousands of employees through expanded partnerships.
“At Moderna, we strongly believe that our work with ChatGPT and OpenAI will change the world. We are looking at every business process, from legal to research to manufacturing to commercial, and figuring out how to redesign them. AI,” Moderna CEO Stéphane Bancel said in a statement.
bigger trends
OpenAI made ChatGPT Enterprise generally available last November. General users can create customized versions. Chat GPT It helps with specific tasks and activities in daily life, such as becoming a better cook or a better negotiator.
Experts say ChatGPT has big promise We contribute to drug discovery by combining natural language processing and innovative drug development. Still, there are limitations such as ChatGPT's inability to account for, or trace the source of, prediction results.
Additionally, the data within the current version of ChatGPT is not up to date.
OpenAI website state“ChatGPT is not connected to the internet and may produce inaccurate answers. Our knowledge of the world and events in 2021 and beyond is limited, and in some cases may produce harmful instructions or biased content. There is a possibility that
Despite its limitations, many digital health companies are leveraging ChatGPT within their services. Hyro, the maker of his GPT-enabled conversational AI provider for healthcare, $20 million in Series B funding Last year, we raised $35 million.